The NICE Guidelines and Pediatric Sedation in the United Kingdom

2018 ◽  
pp. 306-312
Author(s):  
Michael Sury ◽  
Sarah Greenaway
Keyword(s):  
United Kingdom ◽  
National Health Service ◽  
Clinical Excellence ◽  
Nice Guidelines ◽  
Safety And Efficacy ◽  
Government Organization ◽  
The United Kingdom ◽  
Pediatric Sedation ◽  
Consensus View ◽  
The Uk

Pediatric procedural sedation is required for children across the globe in a wide variety of circumstances. In the United Kingdom, the National Institute for Health and Clinical Excellence (NICE) is a government organization whose purpose is to provide guidelines to help ensure that patients receive effective, good-value healthcare across the whole of the National Health Service. In 2010 NICE published a guideline for the use of pediatric sedation. The overarching aims were to review the safety and efficacy of sedation for common procedures and to form a consensus view on the necessary resources to do this safely. This chapter summarizes the key recommendations and describes how pediatric sedation has since evolved in the UK.

scholarly journals The potential impact of increased treatment rates for alcohol dependence in the United Kingdom in 2004

2021 ◽  
Author(s):  
Kevin D. Shield ◽  
Jürgen Rehm ◽  
Maximilien X. Rehm ◽  
Gerrit Gmel ◽  
Colin Drummond
Keyword(s):  
United Kingdom ◽  
Alcohol Consumption ◽  
Alcohol Dependence ◽  
Burden Of Disease ◽  
Pharmacological Treatment ◽  
Clinical Excellence ◽  
Sensitivity Analyses ◽  
Treatment Coverage ◽  
The United Kingdom ◽  
The Uk

Alcohol consumption has been linked to a considerable burden of disease in the United Kingdom (UK), with most of this burden due to heavy drinking and Alcohol Dependence (AD). However, AD is undertreated in the UK, with only 8% of those individuals with AD being treated in England and only 6% of those individuals with AD being treated in Scotland. Thus, the objective of this paper is to quantify the deaths that would have been avoided in the UK in 2004 if the treatment rate for AD had been increased. Methods Data on the prevalence of AD, alcohol consumption, and mortality were obtained from the Adult Psychiatric Morbidity Survey, the Global Information System on Alcohol and Health, and the 2004 Global Burden of Disease study respectively. Data on the effectiveness of pharmacological treatment and Motivational Interviewing/Cognitive Behavioural Therapy were obtained from Cochrane reviews and meta-analyses. Simulations were used to model the number of deaths under different treatment scenarios. Sensitivity analyses were performed to model the effects of Brief Interventions and to examine the effect of using AD prevalence data obtained from the National Institute for Health and Clinical Excellence. Results In the UK, 320 female and 1,385 male deaths would have been avoided if treatment coverage of pharmacological treatment had been increased to 20%. This decrease in the number of deaths represents 7.9% of all alcohol-attributable deaths (7.0% of all alcohol-attributable deaths for women and 8.1% of all alcohol-attributable deaths for men). If we used lower AD prevalence rates obtained from the National Institute for Health and Clinical Excellence, then treatment coverage of pharmacological treatment in hospitals for 20% of the population with AD would have resulted in the avoidance of 529 deaths in 2004 (99 deaths avoided for women and 430 deaths avoided for men). Conclusions Increasing AD treatment in the UK would have led to a large number of deaths being avoided in 2004. Increased AD treatment rates not only impact mortality but also impact upon the large burden of disability and morbidity attributable to AD, as well as the associated social and economic burdens.

scholarly journals The potential impact of increased treatment rates for alcohol dependence in the United Kingdom in 2004

2021 ◽  
Author(s):  
Kevin D. Shield ◽  
Jürgen Rehm ◽  
Maximilien X. Rehm ◽  
Gerrit Gmel ◽  
Colin Drummond
Keyword(s):  
United Kingdom ◽  
Alcohol Consumption ◽  
Alcohol Dependence ◽  
Burden Of Disease ◽  
Pharmacological Treatment ◽  
Clinical Excellence ◽  
Sensitivity Analyses ◽  
Treatment Coverage ◽  
The United Kingdom ◽  
The Uk

Alcohol consumption has been linked to a considerable burden of disease in the United Kingdom (UK), with most of this burden due to heavy drinking and Alcohol Dependence (AD). However, AD is undertreated in the UK, with only 8% of those individuals with AD being treated in England and only 6% of those individuals with AD being treated in Scotland. Thus, the objective of this paper is to quantify the deaths that would have been avoided in the UK in 2004 if the treatment rate for AD had been increased. Methods Data on the prevalence of AD, alcohol consumption, and mortality were obtained from the Adult Psychiatric Morbidity Survey, the Global Information System on Alcohol and Health, and the 2004 Global Burden of Disease study respectively. Data on the effectiveness of pharmacological treatment and Motivational Interviewing/Cognitive Behavioural Therapy were obtained from Cochrane reviews and meta-analyses. Simulations were used to model the number of deaths under different treatment scenarios. Sensitivity analyses were performed to model the effects of Brief Interventions and to examine the effect of using AD prevalence data obtained from the National Institute for Health and Clinical Excellence. Results In the UK, 320 female and 1,385 male deaths would have been avoided if treatment coverage of pharmacological treatment had been increased to 20%. This decrease in the number of deaths represents 7.9% of all alcohol-attributable deaths (7.0% of all alcohol-attributable deaths for women and 8.1% of all alcohol-attributable deaths for men). If we used lower AD prevalence rates obtained from the National Institute for Health and Clinical Excellence, then treatment coverage of pharmacological treatment in hospitals for 20% of the population with AD would have resulted in the avoidance of 529 deaths in 2004 (99 deaths avoided for women and 430 deaths avoided for men). Conclusions Increasing AD treatment in the UK would have led to a large number of deaths being avoided in 2004. Increased AD treatment rates not only impact mortality but also impact upon the large burden of disability and morbidity attributable to AD, as well as the associated social and economic burdens.

UK politics prolongs doubt over relations with Trump

2019 ◽  
Keyword(s):  
United Kingdom ◽  
National Health Service ◽  
Northern Ireland ◽  
Content Type ◽  
Us Congress ◽  
The United Kingdom ◽  
Intelligence Sharing ◽  
The Us ◽  
The Uk ◽  
Large Sections

Subject Future UK-US relations. Significance During his state visit to the United Kingdom, US President Trump took a conciliatory line towards his hosts. There was little substantive progress on bilateral issues, but neither was there open disagreement. Trump appeared to walk back a threat to cut off intelligence-sharing with the United Kingdom over London’s stance towards China, and he also attempted to minimise the damage he caused by suggesting the National Health Service (NHS) should be part of a future US-UK trade deal. Impacts Trump remains unpopular among large sections of the UK public, which makes it risky for Conservative politicians to appear close to him. Trump suggested that Nigel Farage should become the UK’s chief Brexit negotiator, indicating he still holds hard-line views on Brexit. A hard border in Northern Ireland after Brexit would complicate the already-difficult politics of a US-UK trade deal in the US Congress.

scholarly journals Redeployment of ophthalmologists in the United Kingdom during the Coronavirus Disease Pandemic

2020 ◽  
pp. 112067212095333 ◽  
Author(s):  
Christina Lim ◽  
Ian De Silva ◽  
George Moussa ◽  
Tahir Islam ◽  
Lina Osman ◽  
...  
Keyword(s):  
Public Health ◽  
United Kingdom ◽  
National Health Service ◽  
Health Service ◽  
Personal Protection ◽  
Prior Training ◽  
Personal Protection Equipment ◽  
The United Kingdom ◽  
The Uk ◽  
Good Support

Background: During the current coronavirus (COVID-19) pandemic, some ophthalmologists across the United Kingdom (UK) have been redeployed to areas of need across the National Health Service (NHS). This survey was performed to assess aspects of this process including training & education, tasks expected, availability of personal protection equipment (PPE) used and the overall anxiety of ophthalmologists around their redeployment. Method: Online anonymous survey around the existing guidance on safe redeployment of secondary care NHS staff and PPE use by NHS England and Public Health England respectively. The survey was open to all ophthalmologists across the UK irrespective of their redeployment status. Findings: 145 surveys were completed and returned during a 2-week period between 17th April 2020 and 1st May 2020, when 52% of ophthalmologists were redeployed. The majority of this group consisted of ophthalmologists in training (79%). 81% of those redeployed were assigned to areas of the hospital where patients with confirmed Coronavirus disease were being treated as inpatients. There was a statistically significant improvement in anxiety level following redeployment which was mainly attributed to the support received by staff within the redeployed area. 71% of the redeployed group were found to have sufficient PPE was provided for the area they worked in. Interpretation: This is the first national survey performed on redeployment of ophthalmologists in the UK. The study showed that ophthalmologists across all grades were able to contribute in most aspects of patient care. Anxiety of redeployment was reduced by prior training and good support in the redeployment area.

Recruitment of cancer patients to National Institute for Health research cancer research network portfolio studies between 2001 and 2011.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. 6091-6091 ◽  
Author(s):  
Matthew Cooper ◽  
Karen Poole ◽  
David A. Cameron ◽  
Robert Haward ◽  
Peter John Selby ◽  
...  
Keyword(s):  
Cancer Research ◽  
United Kingdom ◽  
National Health Service ◽  
Health Service ◽  
Cancer Patients ◽  
Health Research ◽  
Research Network ◽  
Cancer Research Network ◽  
The United Kingdom ◽  
The Uk

6091 Background: The National Institute for Health Research Cancer Research Network (NCRN) was established in 2001 in England, United Kingdom to improve cancer patient outcomes by improving the coordination, integration and speed of cancer research. Methods: Baseline recruitment of cancer patients in England to clinical studies was around 4% of incident population. Research Networks were established initially in England (NCRN) and then across the UK, co-terminus with clinical cancer service networks, and a per capita based funding model used to provide a research infrastructure to support recruitment to a nationally defined research portfolio. Results: Within 3 years, as the networks were established, recruitment of patients to studies doubled from 10,000 to 20,000 cancer patients per year. Recruitment has continued to increase year on year, supported initially by underspend that had accrued from earlier years in the life of NCRN, and more recently from additional resources invested via the NIHR comprehensive networks. Data for 2010/11 show that over 45,000 cancer patients are now recruited into portfolio studies in England each year, with over 50,000 across the whole of the UK. Conclusions: Dedicated, targeted, clinician-led National Health Service investment into supporting national portfolio studies, has delivered an unprecedented five-fold increase in recruitment of cancer patients into clinical trials across the United Kingdom. This required coordinated research infrastructure, close cooperation with research funders, particularly Cancer Research UK and the National Cancer Research Institute, and the enthusiasm and hard work of many clinicians, patients and others working to deliver clinical cancer care in the National Health Service in the United Kingdom.

Health Systems in the United Kingdom and Their Role in Increasing Equity

PEDIATRICS ◽  
2003 ◽  
Vol 112 (Supplement_3) ◽  
pp. 716-720
Author(s):  
Leslie Davidson
Keyword(s):  
United States ◽  
Health Care ◽  
United Kingdom ◽  
National Health Service ◽  
Health Service ◽  
The United States ◽  
Personal Reflection ◽  
Levels Of Care ◽  
The United Kingdom ◽  
The Uk

The Issue. This article describes the organization of the National Health Service with respect to the primary and secondary levels of care it offers children. It begins with a personal reflection from 17 years ago that is still relevant to the challenges confronting families in the United Kingdom today. It will discuss the basics of what is different and what is similar when comparing the UK health care system to that of the United States.

Criteria for Approval of Training Programmes for Senior Registrars in Orthodontics in the United Kingdom

1989 ◽  
Vol 16 (4) ◽  
pp. 285-288
Author(s):  
H. S. Orton
Keyword(s):  
United Kingdom ◽  
National Health Service ◽  
Health Service ◽  
Paediatric Dentistry ◽  
Senior Registrar ◽  
The United Kingdom ◽  
Training Post ◽  
Training Programmes ◽  
The Uk ◽  
Registrar Training

To be appointed as a consultant orthodontist in the British National Health Service requires a period of 3 + years in a higher training post as a senior registrar in orthodontics. Educational approval of these training posts is controlled by the Joint Committee for Higher Training in Dentistry. The detailed monitoring and requirements of senior registrar training posts are controlled by the Specialist Advisory Committee in Orthodontics and Paediatric Dentistry. Revised criteria for the approval of training programmes have recently been issued and are appended for the guidance of aspirant trainees, trainers and for the reader seeking an understanding of the UK title of ‘Consultant Orthodontist’.

scholarly journals Provision of exercise services in patients with peripheral artery disease in the United Kingdom

Vascular ◽  
2021 ◽  
pp. 170853812110352
Author(s):  
Amy E Harwood ◽  
Sean Pymer ◽  
Said Ibeggazene ◽  
Lee Ingle ◽  
Eddie Caldow ◽  
...  
Keyword(s):  
United Kingdom ◽  
Online Survey ◽  
Exercise Programme ◽  
Walking Distance ◽  
Nice Guidelines ◽  
The United Kingdom ◽  
Supervised Exercise ◽  
Ethical Approval ◽  
Exercise Programmes ◽  
The Uk

Objectives Supervised exercise programmes (SEPs) are a vital treatment for people with intermittent claudication, leading improvements in walking distance and quality of life and are recommended in multiple national and international guidelines. We aimed to evaluate the use and structure of SEPs in the United Kingdom (UK). Design We conducted an anonymous online survey using the Jisc platform comprising of 40 questions. The survey was designed to address key areas such as access, provision, uptake and delivery of SEPs in the United Kingdom. Ethical approval was obtained from Coventry University (P108729). Methods The list of trusts providing vascular services was obtained from the National Vascular Registry (NVR) report. The survey was disseminated via social media, The Vascular Society of Great Britain and Ireland and the Society for Vascular Technology. Data were exported to a Microsoft Excel document and analysed using simple descriptive statistics. Results Of 93 vascular units identified, we received response from 48. Of these, 23 had access to an exercise programme (48%). The majority of SEPs were exclusively for PAD patients (77%), with 21% using integrated services. 67% of respondents were providing a circuit-based programme, and 5 out of 23 were meeting the dose recommendations in the UK National Institute for Health and Care Excellence (NICE) guidelines. Respondents felt that programmes were moderately to extremely important to patients, slightly to very important to clinicians and not at all important to slightly important to commissioning/funding bodies. Conclusion SEPs are a well-established first-line treatment for patients with IC and they are recommended by NICE guidelines. Despite this, many patients still do not have access to an exercise programme, and clinicians do not feel that they have support from commissioning/funding bodies to develop them. There is an urgent need for funding, development and delivery of SEPs in the United Kingdom.

TBE in United Kingdom

2020 ◽  
Keyword(s):  
United Kingdom ◽  
Clinical Disease ◽  
England And Wales ◽  
Probable Case ◽  
The United Kingdom ◽  
South West ◽  
Louping Ill ◽  
The Uk ◽  
North And South ◽  
South West England

Until 2019, TBE was considered only to be an imported disease to the United Kingdom. In that year, evidence became available that the TBEV is likely circulating in the country1,2 and a first “probable case” of TBE originating in the UK was reported.3 In addition to TBEV, louping ill virus (LIV), a member of the TBEV-serocomplex, is also endemic in parts of the UK. Reports of clinical disease caused by LIV in livestock are mainly from Scotland, parts of North and South West England and Wales.4

Risk Transferin Public Private Partnership/Private Finance Initiative Procurement Documents:The Differencebetween The United Kingdom and Malaysia

2016 ◽  
Vol 4 (4) ◽  
pp. 30
Author(s):  
Nooriha Abdullah ◽  
Darinka Asenova ◽  
Stephen J. Bailey
Keyword(s):  
United Kingdom ◽  
Public Procurement ◽  
Research Question ◽  
Public Private Partnership ◽  
Private Finance Initiative ◽  
Private Partnership ◽  
Risk Transfer ◽  
Private Finance ◽  
The United Kingdom ◽  
The Uk

The aim of this paper is to analyse the risk transfer issue in Public Private Partnership/Private Finance Initiative (PPP/PFI) procurement documents in the United Kingdom (UK) and Malaysia. It utilises qualitative research methods using documentation and interviews for data collection. The UK documents (guidelines and contracts) identify the risks related to this form of public procurement of services and makeexplicittheappropriateallocation of those risks between the public and the private sector PPP/PFI partners and so the types of risks each party should bear. However, in Malaysia, such allocation of risks was not mentioned in PPP/PFI guidelines. Hence, a question arises regarding whether risk transfer exists in Malaysian PPP/PFI projects, whether in contracts or by other means. This research question is the rationale for the comparative analysis ofdocumentsand practicesrelatingtorisk transfer in the PPP/PFI procurements in both countries. The results clarify risk-related issues that arise in implementing PPP/PFI procurement in Malaysia, in particular how risk is conceptualised, recognised and allocated (whether explicitly or implicitly), whether or not that allocation is intended to achieve optimum risk transfer, and so the implications forachievement ofvalue for moneyor other such objectivesinPPP/PFI.

Sign in / Sign up

Export Citation Format

Share Document